Articles

Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial

Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia;PhD course in Experimental Medicine, University of Pavia, Pavia
Department of Medicine, University of Perugia, Perugia
Department of Medicine, University of Padova, Padova
Service of Clinical Epidemiology & Biometry, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia
IRCCS Policlinico Universitario A. Gemelli Foundation, Roma;Institute of Internal Medicine and Geriatrics, Catholic University of the Sacred Heart, Roma
Department of Medicine, Section of Hematology, University of Verona, Verona
Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia
Department of Medicine, University of Perugia, Perugia
IRCCS Policlinico Universitario A. Gemelli Foundation, Roma
Service of Clinical Epidemiology & Biometry, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia
Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia
Department of Medicine, University of Padova, Padova
Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia;Ferrata-Storti Foundation, Pavia, Italy.
Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia
Vol. 105 No. 3 (2020): March, 2020 https://doi.org/10.3324/haematol.2019.223966